Patent details

EP3285809 Title: INHIBITORS OF IMMUNE CHECKPOINT MODULATORS FOR USE IN TREATING CANCER AND INFECTIONS

Basic Information

Publication number:
EP3285809
PCT Application Number:
US2016027870
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP167196559
PCT Publication Number:
WO2016172010
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INHIBITORS OF IMMUNE CHECKPOINT MODULATORS FOR USE IN TREATING CANCER AND INFECTIONS
French Title of Invention:
MODULATEURS IMMUNITAIRE DES POINTS DE CONTRÔLE POUR LE TRAITEMENT DU CANCER ET DES INFECTIONS
German Title of Invention:
IMMUNPRÜFPUNKTMODULATOREN ZUR BEHANDLUNG VON KREBS UND INFEKTIONEN
SPC Number:

Dates

Filing date:
15/04/2016
Grant date:
11/09/2019
EP Publication Date:
28/02/2018
PCT Publication Date:
27/10/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/09/2019
EP B1 Publication Date:
11/09/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
15/04/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/09/2019
 
 

Name:
eFFECTOR Therapeutics, Inc.
Address:
11180 Roselle Street, San Diego, California 92121, United States (US)

Agent

Name:
Dennemeyer & Associates S.A.
From:
04/11/2019
Address:
55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)
To:

Inventor

1

Name:
GOEL, Vikas
Address:
United States (US)

2

Name:
WEBSTER, Kevin, R.
Address:
United States (US)

Priority

1

Priority Number:
201562150140 P
Priority Date:
20/04/2015
Priority Country:
United States (US)

2

Priority Number:
201562260917 P
Priority Date:
30/11/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/00; A61K 31/506; A61K 31/713; A61K 39/395; A61K 45/06; A61P 31/00; A61P 35/00; A61P 37/04;

Publication

European Patent Bulletin

Issue number:
201937
Publication date:
11/09/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/04/2025
Annual Fee Number:
10
Annual Fee Amount:
131 Euro
Expected Payer:
Last Annual Fee Payment Date:
11/04/2024
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
115 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
04/11/2019 Power Of Attorney 2
05/11/2019 Outgoing Correspondence 1